⌘K

Login Start Free

Home/Filings/4/0001474506-25-000103

4//SEC Filing

Kogan Elona 4

Accession 0001474506-25-000103

CIK 0001894525other

View on SEC.gov Company Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:18 PM ET

Size

5.4 KB

Accession

0001474506-25-000103

Insider Transaction Report

Form 4

Period: 2025-05-16

Apimeds Pharmaceuticals US, Inc.APUS

Director

Transactions

Award
Stock Option (right to buy)
2025-05-16+5,780→ 5,780 total
Exercise: $1.73Exp: 2035-05-16→ Common Stock, par value $0.01 per share (5,780 underlying)

Footnotes (1)

[F1]The option will vest in full and become exercisable on 05/16/2026.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apimeds Pharmaceuticals US, Inc.

CIK 0001894525

Entity typeother

Related Parties

1

filerCIK 0001679971

Filing Metadata

Form type: 4
Filed: May 19, 8:00 PM ET
Accepted: May 20, 5:18 PM ET
Size: 5.4 KB

View on SEC.gov